Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Dalgleish

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1993
Should we be using 5-HT3 antagonists as first line antiemetic therapy in cisplatin-based chemotherapy?J L Mansi, T R Evans, A Smith, et al.
Clinical and Experimental Immunology|October 23, 2004
The common heat shock protein receptor CD91 is up-regulated on monocytes of advanced melanoma slow progressorsJ Stebbing, M Bower, B Gazzard, et al.
British Journal of Cancer|April 23, 2009
T-regulatory cell modulation: the future of cancer immunotherapy?S Nizar, J Copier, B Meyer, et al.
AIDS (London, England)|January 12, 2000
The conserved carboxy terminal region of HIV-1 gp120 is recognized by seronegative HIV-exposed peopleL Brown, B E Souberbielle, J B Marriott, et al.
Biochemical and Biophysical Research Communications|August 30, 1991
HIV-1 proteinase is required for synthesis of pro-viral DNAC Baboonian, A Dalgleish, L Bountiff, et al.
Clinical and Experimental Immunology|April 11, 2022
Bacillus Calmette-Guerin (BCG) induces superior anti-tumour responses by Vδ2+ T cells compared with the aminobisphosphonate drug zoledronic acidJ Fenn, L A Ridgley, A White, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2011
An intra-patient placebo-controlled phase I trial to evaluate the safety and tolerability of intradermal IMM-101 in melanomaJ Stebbing, A Dalgleish, A Gifford-Moore, et al.
The Journal of the Acoustical Society of America|March 3, 2018
An approach for automatic classification of grouper vocalizations with passive acoustic monitoringAli K Ibrahim, Laurent M Chérubin, Hanqi Zhuang, et al.
AIDS Research and Human Retroviruses|December 1, 1988
HTLV-1 infection in tropical spastic paraparesis: lymphocyte culture and serologic responseA Dalgleish, J Richardson, E Matutes, et al.
Lancet (London, England)|July 21, 1984
Low prevalence in the UK of HTLV-I and HTLV-II infection in subjects with AIDS, with extended lymphadenopathy, and at risk of AIDSR S Tedder, D C Shanson, D J Jeffries, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1993
Should we be using 5-HT3 antagonists as first line antiemetic therapy in cisplatin-based chemotherapy?J L Mansi, T R Evans, A Smith, et al.
Clinical and Experimental Immunology|October 23, 2004
The common heat shock protein receptor CD91 is up-regulated on monocytes of advanced melanoma slow progressorsJ Stebbing, M Bower, B Gazzard, et al.
British Journal of Cancer|April 23, 2009
T-regulatory cell modulation: the future of cancer immunotherapy?S Nizar, J Copier, B Meyer, et al.
AIDS (London, England)|January 12, 2000
The conserved carboxy terminal region of HIV-1 gp120 is recognized by seronegative HIV-exposed peopleL Brown, B E Souberbielle, J B Marriott, et al.
Biochemical and Biophysical Research Communications|August 30, 1991
HIV-1 proteinase is required for synthesis of pro-viral DNAC Baboonian, A Dalgleish, L Bountiff, et al.
Clinical and Experimental Immunology|April 11, 2022
Bacillus Calmette-Guerin (BCG) induces superior anti-tumour responses by Vδ2+ T cells compared with the aminobisphosphonate drug zoledronic acidJ Fenn, L A Ridgley, A White, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2011
An intra-patient placebo-controlled phase I trial to evaluate the safety and tolerability of intradermal IMM-101 in melanomaJ Stebbing, A Dalgleish, A Gifford-Moore, et al.
The Journal of the Acoustical Society of America|March 3, 2018
An approach for automatic classification of grouper vocalizations with passive acoustic monitoringAli K Ibrahim, Laurent M Chérubin, Hanqi Zhuang, et al.
AIDS Research and Human Retroviruses|December 1, 1988
HTLV-1 infection in tropical spastic paraparesis: lymphocyte culture and serologic responseA Dalgleish, J Richardson, E Matutes, et al.
Lancet (London, England)|July 21, 1984
Low prevalence in the UK of HTLV-I and HTLV-II infection in subjects with AIDS, with extended lymphadenopathy, and at risk of AIDSR S Tedder, D C Shanson, D J Jeffries, et al.
Pageof 6